1 Day
Source:
USA TODAY
USA TODAY
Ready to play
Ready to play
The FDA is considering approving seven unapproved peptides for use in compounded prescription drugs, despite safety concerns raised by the agency. These peptides, popular for their purported health benefits, may pose risks such as heart toxicity, infections, and other serious adverse effects, as past bans have indicated. Peptides are short amino acid chains essential for various bodily functions, and their use in health and wellness circles is increasing amid ongoing regulatory scrutiny.
Notice: This Is an AI-Generated Summary
Comments (0)